TMC125-C203: Phase II Randomized (Patients Are Assigned Different Treatments Based on Chance), Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected Patients

Name: TMC125-C203: Phase II Randomized (Patients Are Assigned Different Treatments Based on Chance), Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected Patients
Published: 2002
License: Public Domain

Tibotec Pharmaceuticals, Ireland · 2002

ClinicalTrials.gov · Datasets · License: Public Domain · 2002

Open Source ↗

aids hiv hiv-1

anti-retroviral agents, hiv-1, hiv, aids, dose finding study, tmc125-c203, treatment experienced, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

TMC125-C203: Phase II Randomized (Patients Are Assigned Different Treatments Based on Chance), Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected Patients

Related documents